CONTRAST-INDUCED NEPHROPATHY
Clinical trials for CONTRAST-INDUCED NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new CONTRAST-INDUCED NEPHROPATHY trials appear
Sign up with your email to follow new studies for CONTRAST-INDUCED NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood pressure pill pause may protect kidneys during heart procedure
Disease control CompletedThis study tested whether stopping a common blood pressure medicine (Ramipril) before a heart artery scan reduces the risk of kidney damage from the dye used. 44 adults were randomly assigned to either stop the medicine 2 days before the scan or keep taking it. Researchers measur…
Matched conditions: CONTRAST-INDUCED NEPHROPATHY
Phase: NA • Sponsor: Tanta University • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
Common drug may shield kidneys from dye damage in ICU
Prevention CompletedThis study looked at whether pentoxifylline, a drug that improves blood flow, could prevent kidney injury caused by contrast dye used in medical imaging. Researchers studied 70 adults with chronic kidney disease in the intensive care unit who needed dye for procedures like heart …
Matched conditions: CONTRAST-INDUCED NEPHROPATHY
Phase: NA • Sponsor: Tanta University • Aim: Prevention
Last updated May 26, 2026 05:46 UTC